Effect of gradual rise in plasma calcium concentration on the impairment of atrioventricular nodal conduction due to verapamil.
The possible reversal by calcium of the inhibitory action of verapamil on the atrioventricular (AV) node was investigated in anesthetized, atropinized dogs, with cardiac pacing. The His bundle potentials were recorded by endocavitory electrode and the AV node effective refractory period measured by the extrastimulus method. Calcium infusion was effective against the impairment of AV nodal conduction induced by verapamil, provided it remained moderate: the gradual rise in the plasma calcium concentration counteracted the effects of an infusion of verapamil on conduction time and effective refractory period in the AV node, as long as it did not exceed 5 mmol/L. However, beyond this level, calcium appeared less and less capable of reversing the effects of verapamil. Thus, the protective action of calcium had a bell-shaped dose-response curve, with the optimum at 5 mmol/L. This biphasic influence is consistent with the opposite opinions previously given concerning the antagonism between calcium and calcium blockers, depending on whether hypercalcemia brought into play was mild or major. In any case, the prominent role played by calcium in the slow inward current in the AV node accounts for the antagonism, observed in vivo, between calcium and verapamil. The pacemaker activity of the sinoatrial (SA) node was less influenced by both calcium blocker and calcium.
J
J
Lang
Q
Q
Timour-Chah
M
M
el Chebly
G
G
Faucon
D000818:Animals; D001283:Atrioventricular Node / Q000187:drug effects* / Q000502:physiology; D002118:Calcium / Q000097:blood*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D004285:Dogs; D004594:Electrophysiology; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects*; D006934:Hypercalcemia / Q000503:physiopathology; D007473:Ion Channels / Q000187:drug effects; D008297:Male; D012849:Sinoatrial Node / Q000187:drug effects / Q000502:physiology; D014700:Verapamil / Q000494:pharmacology*
D002121:Calcium Channel Blockers; D007473:Ion Channels; D014700:Verapamil; D002118:Calcium